Geoffrey L Greene

Title: Inventor Geoffrey L. Greene: Pioneering Cancer Treatment Innovations

Introduction

Geoffrey L. Greene is a prominent inventor based in Chicago, IL, who has made significant contributions to the field of cancer treatment through his innovative work. With a total of six patents to his name, Greene has focused his research on advancing therapies for estrogen receptor-positive cancers and androgen receptor modulation.

Latest Patents

Among his latest patents is a groundbreaking treatment method for aromatase-resistant estrogen receptor-positive (ER+) cancer. This patent discloses methods for treating patients who have shown progression on an aromatase inhibitor, specifically targeting ER+ cancers without a gain of function missense mutation in the ligand binding domain of the Estrogen Receptor 1 (ESR1) gene. The invention centers around the administration of lasofoxifene, along with its pharmaceutically acceptable salts, prodrugs, or functional derivatives.

Another significant patent by Greene involves compounds that serve as modulators, agonists, or antagonists of the androgen receptor (AR). This innovation provides compositions and methodologies for the effective utilization of these compounds in cancer treatment.

Career Highlights

Geoffrey Greene has had notable affiliations with respected institutions such as Memorial Sloan Kettering Cancer Center and the University of Chicago. His work in these prominent organizations has allowed him to be at the forefront of cancer research, leading to the development of innovative treatment options.

Collaborations

Throughout his career, Greene has collaborated with esteemed professionals in the field, including Minna Delarae Balbas and Michael J. Evans. These partnerships have been instrumental in advancing his research and the successful translation of his inventions into practical applications.

Conclusion

Geoffrey L. Greene's contributions to cancer treatment represent a significant leap forward in the fight against the disease. Through his patents and collaborative efforts, he continues to shed light on effective therapeutic strategies, ultimately benefiting patients and advancing medical science. His work serves as an inspiration for future inventors and researchers in the realm of oncology.